© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 4, 347-354,
February 17, 1999
© 1999 Oxford University Press
ARTICLES |
Protective Alterations in Phase 1 and 2 Metabolism of Aflatoxin B1 by Oltipraz in Residents of Qidong, People's Republic of China
Affiliations of authors: J.-S. Wang, X. Shen, X. He, A.Zarba, P. A. Egner, J. D. Groopman, T. W. Kensler (Department of Environmental Health Sciences), L. P. Jacobson, A. Muñoz, K. J. Helzlsouer (Department of Epidemiology), The Johns Hopkins University, Baltimore, MD; Y.-R. Zhu, B.-C. Zhang, J.-B. Wang, Qidong Liver Cancer Institute, Qidong, Jiangsu Province, People's Republic of China; G.-S. Qian, S.-Y. Kuang, Shanghai Cancer Institute, Shanghai, People's Republic of China.
Correspondence to: Thomas W. Kensler, Ph.D., Department of Environmental Health Sciences, The Johns Hopkins School of Hygiene and Public Health, 615 N. Wolfe St., Baltimore, MD 21205 (e-mail: tkensler{at}jhsph.edu).
BACKGROUND: Residents of Qidong, People's Republic of China, are at high risk for development of hepatocellular carcinoma, in part due to consumption of foods contaminated with aflatoxins, which require metabolic activation to become carcinogenic. In a randomized, placebo-controlled, double-blind phase IIa chemoprevention trial, we tested oltipraz, an antischistosomal drug that has been shown to be a potent and effective inhibitor of aflatoxin-induced hepatocarcinogenesis in animal models. METHODS: In 1995, 234 adults from Qidong were enrolled. Healthy eligible individuals were randomly assigned to receive by mouth 125 mg oltipraz daily, 500 mg oltipraz weekly, or a placebo. Sequential immunoaffinity chromatography and liquid chromatography coupled to mass spectrometry or to fluorescence detection were used to identify and quantify phase 1 and phase 2 metabolites of aflatoxin B1 in the urine of study participants. Reported P values are two-sided. RESULTS: One month of weekly administration of 500 mg oltipraz led to a 51% decrease in median levels of the phase 1 metabolite aflatoxin M1 excreted in urine compared with administration of a placebo (P = .030), but it had no effect on levels of a phase 2 metabolite, aflatoxin-mercapturic acid (P = .871). By contrast, daily intervention with 125 mg oltipraz led to a 2.6-fold increase in median aflatoxin-mercapturic acid excretion (P = .017) but had no effect on excreted aflatoxin M1 levels (P = .682). CONCLUSIONS: Intermittent, high-dose oltipraz inhibited phase 1 activation of aflatoxins, and sustained low-dose oltipraz increased phase 2 conjugation of aflatoxin, yielding higher levels of aflatoxin-mercapturic acid. While both mechanisms can contribute to protection, this study highlights the feasibility of inducing phase 2 enzymes as a chemopreventive strategy in humans.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. H. Lee, Y. W. Kim, J. H. Choi, S. C. Brooks III, M.-O. Lee, and S. G. Kim Oltipraz and dithiolethione congeners inhibit hypoxia-inducible factor-1{alpha} activity through p70 ribosomal S6 kinase-1 inhibition and H2O2-scavenging effect Mol. Cancer Ther., October 1, 2009; 8(10): 2791 - 2802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. N. Kwon, S. M. Shin, I. J. Cho, and S. G. Kim Oxidized Metabolites of Oltipraz Exert Cytoprotective Effects against Arachidonic Acid through AMP-Activated Protein Kinase-Dependent Cellular Antioxidant Effect and Mitochondrial Protection Drug Metab. Dispos., June 1, 2009; 37(6): 1187 - 1197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Wild Environmental exposure measurement in cancer epidemiology Mutagenesis, March 1, 2009; 24(2): 117 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. T. Tran, L. Xu, V. Phan, S. B. Goodwin, M. Rahman, V. X. Jin, C. H. Sutter, B. D. Roebuck, T. W. Kensler, E.O. George, et al. Chemical genomics of cancer chemopreventive dithiolethiones Carcinogenesis, March 1, 2009; 30(3): 480 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Shin and S. G. Kim Inhibition of Arachidonic Acid and Iron-Induced Mitochondrial Dysfunction and Apoptosis by Oltipraz and Novel 1,2-Dithiole-3-thione Congeners Mol. Pharmacol., January 1, 2009; 75(1): 242 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang and R. Munday Dithiolethiones for cancer chemoprevention: where do we stand? Mol. Cancer Ther., November 1, 2008; 7(11): 3470 - 3479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Liby, M. M. Yore, B. D. Roebuck, K. J. Baumgartner, T. Honda, C. Sundararajan, H. Yoshizawa, G. W. Gribble, C. R. Williams, R. Risingsong, et al. A Novel Acetylenic Tricyclic bis-(Cyano Enone) Potently Induces Phase 2 Cytoprotective Pathways and Blocks Liver Carcinogenesis Induced by Aflatoxin Cancer Res., August 15, 2008; 68(16): 6727 - 6733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tang, M. Tang, L. Xu, H. Luo, T. Huang, J. Yu, L. Zhang, W. Gao, S. B. Cox, and J.-S. Wang Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention Carcinogenesis, February 1, 2008; 29(2): 411 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. J. Wang, J. D. Hayes, C. J. Henderson, and C. R. Wolf Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha PNAS, December 4, 2007; 104(49): 19589 - 19594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Simonich, P. A. Egner, B. D. Roebuck, G. A. Orner, C. Jubert, C. Pereira, J. D. Groopman, T. W. Kensler, R. H. Dashwood, D. E. Williams, et al. Natural chlorophyll inhibits aflatoxin B1-induced multi-organ carcinogenesis in the rat Carcinogenesis, June 1, 2007; 28(6): 1294 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. R. Pokharel, E. H. Han, J. Y. Kim, S. J. Oh, S. K. Kim, E.-R. Woo, H. G. Jeong, and K. W. Kang Potent protective effect of isoimperatorin against aflatoxin B1-inducible cytotoxicity in H4IIE cells: bifunctional effects on glutathione S-transferase and CYP1A Carcinogenesis, December 1, 2006; 27(12): 2483 - 2490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Ko, S. J. Lee, J. W. Kim, J. W. Lim, and S. G. Kim DIFFERENTIAL EFFECTS OF THE OXIDIZED METABOLITES OF OLTIPRAZ ON THE ACTIVATION OF CCAAT/ENHANCER BINDING PROTEIN-{beta} AND NF-E2-RELATED FACTOR-2 FOR GSTA2 GENE INDUCTION Drug Metab. Dispos., August 1, 2006; 34(8): 1353 - 1360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Karuri, Y. Huang, S. Bodreddigari, C. H. Sutter, B. D. Roebuck, T. W. Kensler, and T. R. Sutter 3H-1,2-Dithiole-3-thione Targets Nuclear Factor {kappa}B to Block Expression of Inducible Nitric-Oxide Synthase, Prevents Hypotension, and Improves Survival in Endotoxemic Rats J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 61 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Yates, M.-K. Kwak, P. A. Egner, J. D. Groopman, S. Bodreddigari, T. R. Sutter, K. J. Baumgartner, B.D. Roebuck, K. T. Liby, M. M. Yore, et al. Potent Protection against Aflatoxin-Induced Tumorigenesis through Induction of Nrf2-Regulated Pathways by the Triterpenoid 1-[2-Cyano-3-,12-Dioxooleana-1,9(11)-Dien-28-Oyl]Imidazole Cancer Res., February 15, 2006; 66(4): 2488 - 2494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Lee and S. G. Kim Role of p90 Ribosomal S6-Kinase-1 in Oltipraz-Induced Specific Phosphorylation of CCAAT/Enhancer Binding Protein-beta for GSTA2 Gene Transactivation Mol. Pharmacol., January 1, 2006; 69(1): 385 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Kensler, J.-G. Chen, P. A. Egner, J. W. Fahey, L. P. Jacobson, K. K. Stephenson, L. Ye, J. L. Coady, J.-B. Wang, Y. Wu, et al. Effects of Glucosinolate-Rich Broccoli Sprouts on Urinary Levels of Aflatoxin-DNA Adducts and Phenanthrene Tetraols in a Randomized Clinical Trial in He Zuo Township, Qidong, People's Republic of China Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2605 - 2613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Knoll, C. Ruhe, S. Veeriah, J. Sauer, M. Glei, E. P. Gallagher, and B. L. Pool-Zobel Genotoxicity of 4-Hydroxy-2-Nonenal in Human Colon Tumor Cells Is Associated with Cellular Levels of Glutathione and the Modulation of Glutathione S-Transferase A4 Expression by Butyrate Toxicol. Sci., July 1, 2005; 86(1): 27 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Kelley, E. M. Glaser, J. E. Herndon II, F. Becker, R. Bhagat, Y.-J. Zhang, R. M. Santella, S. G. Carmella, S. S. Hecht, L. Gallot, et al. Safety and Efficacy of Weekly Oral Oltipraz in Chronic Smokers Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 892 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Piton, E. Le Ferrec, S. Langouet, C. Rauch, E. Petit, F. Le Goff, A. Guillouzo, and F. Morel Oltipraz regulates different categories of genes relevant to chemoprevention in human hepatocytes Carcinogenesis, February 1, 2005; 26(2): 343 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H Williams, T. D Phillips, P. E Jolly, J. K Stiles, C. M Jolly, and D. Aggarwal Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1106 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Sharma and P. B. Farmer Biological Relevance of Adduct Detection to the Chemoprevention of Cancer Clin. Cancer Res., August 1, 2004; 10(15): 4901 - 4912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang and G. B. Gordon A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway Mol. Cancer Ther., July 1, 2004; 3(7): 885 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Session 3: Cancer Prevention: Prevention of Liver Cancer THOMAS W. KENSLER, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205 Toxicol Pathol, January 1, 2004; 32(1): 139 - 140. [PDF]
|
|
|
|
 |
|
 M.-K. Kwak, N. Wakabayashi, J. L. Greenlaw, M. Yamamoto, and T. W. Kensler Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling Pathway Mol. Cell. Biol., December 1, 2003; 23(23): 8786 - 8794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Roebuck, T. J. Curphey, Y. Li, K. J. Baumgartner, S. Bodreddigari, J. Yan, S. J. Gange, T. W. Kensler, and T. R. Sutter Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz Carcinogenesis, December 1, 2003; 24(12): 1919 - 1928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Conney Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture Cancer Res., November 1, 2003; 63(21): 7005 - 7031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Ebert, A. Klinder, W. H.M. Peters, A. Schaferhenrich, W. Sendt, J. Scheele, and B. L. Pool-Zobel Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate Carcinogenesis, October 1, 2003; 24(10): 1637 - 1644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Goldman and P. G. Shields Food Mutagens J. Nutr., March 1, 2003; 133(3): 965S - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-K. Kwak, N. Wakabayashi, K. Itoh, H. Motohashi, M. Yamamoto, and T. W. Kensler Modulation of Gene Expression by Cancer Chemopreventive Dithiolethiones through the Keap1-Nrf2 Pathway. IDENTIFICATION OF NOVEL GENE CLUSTERS FOR CELL SURVIVAL J. Biol. Chem., February 28, 2003; 278(10): 8135 - 8145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Kang, I. J. Cho, C. H. Lee, and S. G. Kim Essential Role of Phosphatidylinositol 3-Kinase-Dependent CCAAT/Enhancer Binding Protein {beta} Activation in the Induction of Glutathione S-Transferase by Oltipraz J Natl Cancer Inst, January 1, 2003; 95(1): 53 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wang, T. K. Bammler, and D. L. Eaton Complementary DNA Cloning, Protein Expression, and Characterization of Alpha-Class GSTs from Macaca fascicularis Liver Toxicol. Sci., November 1, 2002; 70(1): 20 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.P. Wild and P.C. Turner The toxicology of aflatoxins as a basis for public health decisions Mutagenesis, November 1, 2002; 17(6): 471 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Brooks, M. F. Goldberg, L. A. Nelson, D. Wu, and W. G. Nelson Identification of Potential Prostate Cancer Preventive Agents through Induction of Quinone Reductase in Vitro Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 868 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lam, C. MacAulay, J. C. le Riche, Y. Dyachkova, A. Coldman, M. Guillaud, E. Hawk, M.-O. Christen, and A. F. Gazdar A Randomized Phase IIb Trial of Anethole Dithiolethione in Smokers with Bronchial Dysplasia J Natl Cancer Inst, July 3, 2002; 94(13): 1001 - 1009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-K. Kwak, K. Itoh, M. Yamamoto, and T. W. Kensler Enhanced Expression of the Transcription Factor Nrf2 by Cancer Chemopreventive Agents: Role of Antioxidant Response Element-Like Sequences in the nrf2 Promoter Mol. Cell. Biol., May 1, 2002; 22(9): 2883 - 2892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nakamura, K. Okazaki, A. Nishikawa, F. Furukawa, K.-I. Kasahara, M. Miyauchi, T. Imazawa, K. Uchida, and M. Hirose Enhancing Effects of Oltipraz on the Development of Spontaneous Hepatic Lesions in LEC Rats Toxicol Pathol, February 1, 2002; 30(2): 173 - 177. [Abstract] [PDF]
|
|
|
|
 |
|
 R. A. Etzel Mycotoxins JAMA, January 23, 2002; 287(4): 425 - 427. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Egner, J.-B. Wang, Y.-R. Zhu, B.-C. Zhang, Y. Wu, Q.-N. Zhang, G.-S. Qian, S.-Y. Kuang, S. J. Gange, L. P. Jacobson, et al. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer PNAS, November 20, 2001; (2001) 251536898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Talalay and J. W. Fahey Phytochemicals from Cruciferous Plants Protect against Cancer by Modulating Carcinogen Metabolism J. Nutr., November 1, 2001; 131(11): 3027S - 3033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Camoirano, M. Bagnasco, C. Bennicelli, C. Cartiglia, J.-B. Wang, B.-C. Zhang, Y.-R. Zhu, G.-S. Qian, P. A. Egner, L. P. Jacobson, et al. Oltipraz Chemoprevention Trial in Qidong, People's Republic of China: Results of Urine Genotoxicity Assays as Related to Smoking Habits Cancer Epidemiol. Biomarkers Prev., July 1, 2001; 10(7): 775 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Wang, S. Abubaker, X. He, G. Sun, P. T. Strickland, and J. D. Groopman Development of Aflatoxin B1-Lysine Adduct Monoclonal Antibody for Human Exposure Studies Appl. Envir. Microbiol., June 1, 2001; 67(6): 2712 - 2717. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. Smela, S. S. Currier, E. A. Bailey, and J. M. Essigmann The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis Carcinogenesis, April 1, 2001; 22(4): 535 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Wolf Chemoprevention: Increased potential to bear fruit PNAS, March 13, 2001; 98(6): 2941 - 2943. [Full Text] [PDF]
|
|
|
|
|
|
M. Ramos-Gomez, M.-K. Kwak, P. M. Dolan, K. Itoh, M. Yamamoto, P. Talalay, and T. W. Kensler From the Cover: Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice PNAS, March 13, 2001; 98(6): 3410 - 3415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Wang, T. Huang, J. Su, F. Liang, Z. Wei, Y. Liang, H. Luo, S.-Y. Kuang, G.-S. Qian, G. Sun, et al. Hepatocellular Carcinoma and Aflatoxin Exposure in Zhuqing Village, Fusui County, People's Republic of China Cancer Epidemiol. Biomarkers Prev., February 1, 2001; 10(2): 143 - 146. [Abstract] [Full Text]
|
|
|
|
|
|
J. G. Lamb and M. R. Franklin Early Events in the Induction of Rat Hepatic UDP-Glucuronosyltransferases, Glutathione S-Transferase, and Microsomal Epoxide Hydrolase by 1,7-Phenanthroline: Comparison with Oltipraz, tert-Butyl-4-hydroxyanisole, and tert-Butylhydroquinone Drug Metab. Dispos., September 1, 2000; 28(9): 1018 - 1023. [Abstract] [Full Text]
|
|
|
|
|
|
F. P. Perera Molecular Epidemiology: On the Path to Prevention? J Natl Cancer Inst, April 19, 2000; 92(8): 602 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Bammler, D. H. Slone, and D. L. Eaton Effects of Dietary Oltipraz and Ethoxyquin on Aflatoxin B1 Biotransformation in Non-Human Primates Toxicol. Sci., March 1, 2000; 54(1): 30 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Kelly, E. M. Ellis, M. M. Manson, S. A. Chanas, G. J. Moffat, R. McLeod, D. J. Judah, G. E. Neal, and J. D. Hayes Chemoprevention of Aflatoxin B1 Hepatocarcinogenesis by Coumarin, a Natural Benzopyrone That Is a Potent Inducer of Aflatoxin B1-Aldehyde Reductase, the Glutathione S-Transferase A5 and P1 Subunits, and NAD(P)H:Quinone Oxidoreductase in Rat Liver Cancer Res., February 1, 2000; 60(4): 957 - 969. [Abstract] [Full Text]
|
|
|
|
|
|
P. A. Egner, J.-B. Wang, Y.-R. Zhu, B.-C. Zhang, Y. Wu, Q.-N. Zhang, G.-S. Qian, S.-Y. Kuang, S. J. Gange, L. P. Jacobson, et al. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer PNAS, December 4, 2001; 98(25): 14601 - 14606. [Abstract] [Full Text] [PDF]
|
|